Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Genzyme General's Seprafilm receives approval in Japan

Sep. 4, 1997

Orally active RARgamma-specific retinoid with selective skin effects

Sep. 2, 1997

Clinical results reported for Senetek's Kinetin

Sep. 2, 1997

Ranitidine shows no benefit in psoriasis

Sep. 2, 1997

Disappointing phase III trial results with interferon gamma for atopic dermatitis

Aug. 29, 1997

Living human tissue approved for marketing in Canada

Aug. 22, 1997

Advisory committee will meet to discuss Synovir NDA

Aug. 21, 1997

Kinetin clinical data to be presented at IBC symposium

Aug. 20, 1997

Penederm launches Avita acne cream

Aug. 19, 1997

The National Psoriasis Foundation warns of potential danger of OTC psoriasis product

Aug. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...